| I. Irritant Dermatitis |
|
|
Electron Paramagnetic Resonance Study for Defining the Mechanism of Irritant Dermatitis |
|
|
3 | (20) |
|
|
|
|
|
|
|
|
|
Irritant Patch Test in Atopic Individuals |
|
|
23 | (8) |
|
|
|
|
|
Quantification of Nonerythematous Irritant Dermatitis |
|
|
31 | (8) |
|
|
|
|
|
|
|
|
|
|
|
39 | (12) |
|
|
|
|
|
Permeability of Skin for Metal Compunds |
|
|
51 | (22) |
|
|
|
Irritant Dermatitis: Subthreshold Irritation |
|
|
73 | (12) |
|
|
|
Cytokines and Irritant Dermatitis Syndrome |
|
|
85 | (20) |
|
|
|
|
|
Assay to Quantify Subjective Irritation Caused by the Pyrethroid Insecticide Alpha-Cypermethrin |
|
|
105 | (10) |
|
|
|
|
|
|
|
Prediction of Skin Corrosivity Using Quantitative Structure-Activity Relationships |
|
|
115 | (14) |
|
|
| II. Percutaneous Absorption |
|
|
Contamination and Percutaneous Absorption of Chemicals from Water and Soil |
|
|
129 | (16) |
|
|
|
|
|
Determining an Occupational Dermal Exposure Biomarker for Atrazine through Measurement of Metabolites in Human Urine by HPLC-Accelerator Mass Spectrometry |
|
|
145 | (14) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Partitioning of Chemicals from Water into Powdered Human Stratum Corneum (Callus) |
|
|
159 | (20) |
|
|
|
|
|
|
|
|
|
Dermal Exposure of Hands to Pesticides |
|
|
179 | (4) |
|
|
|
|
|
183 | (14) |
|
|
|
|
|
Penetration and Barrier Creams |
|
|
197 | (10) |
|
|
|
|
| III. Allergic Contact Dermatitis |
|
|
|
|
207 | (28) |
|
|
|
|
|
Novel Topical Agents for Prevention and Treatment of Allergic and Irritant Contact Dermatitis |
|
|
235 | (28) |
|
|
|
|
|
Allergic Contact Dermatitis: Clinical Considerations |
|
|
263 | (8) |
|
|
|
|
|
Pharmacology, Toxicology, and Immunology of Experimental Contact Sensitizers |
|
|
271 | (22) |
|
|
|
|
|
|
|
Modulation of the Dermal Immune Response by Acute Restraint |
|
|
293 | (14) |
|
|
|
|
|
Textile-Dye Allergic Contact Dermatitis Prevalence |
|
|
307 | (16) |
|
|
|
|
|
Dose-Response Studies in Guinea Pig Allergy Tests |
|
|
323 | (22) |
|
|
|
Operational Definition of Allergic Contact Dermatitis |
|
|
345 | (12) |
|
|
|
|
|
Predictive Immunotoxicological Risk Assessment |
|
|
357 | (14) |
|
|
|
|
|
|
|
Allergic Contact Dermatitis from Transdermal Systems |
|
|
371 | (12) |
|
|
|
|
| IV. Contact Urticaria |
|
|
Animal Models for Immunologic Contact Urticaria and Nonimmunologic Contact Urticaria |
|
|
383 | (6) |
|
|
|
|
|
Diagnostic Tests in Dermatology |
|
|
389 | (14) |
|
|
|
|
|
|
| V. Miscellaneous |
|
|
|
|
403 | (42) |
|
|
|
Issues of Toxicity with Dermatologic Drugs During Pregnancy |
|
|
445 | (44) |
|
|
|
Roles of Calcium Ions in Skin Barrier |
|
|
489 | (12) |
|
|
|
|
|
Nuclear Receptors for Psoralen in Cultured Human Skin Fibroblasts |
|
|
501 | (12) |
|
|
|
|
|
|
|
In Vitro Viability Assays |
|
|
513 | (18) |
|
|
|
Dermal Penetration of Calcium Salts and Calcinosis Cutis |
|
|
531 | (14) |
|
|
| Index |
|
545 | |
Lisainfo e-raamatute kohta